1
|
Terceño M, Bashir S, Cienfuegos J, Murillo A, Vera-Monge VA, Pardo L, Reina M, Gubern-Mérida C, Puigoriol-Illamola D, Carballo L, Costa A, Buxó M, Serena J, Silva Y. General anesthesia versus conscious sedation during endovascular treatment in posterior circulation large vessel occlusion: A systematic review and meta-analysis. Eur Stroke J 2022; 8:85-92. [PMID: 37021193 PMCID: PMC10069205 DOI: 10.1177/23969873221127738] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Accepted: 09/02/2022] [Indexed: 11/15/2022] Open
Abstract
Purpose: The optimal anesthetic approach in the endovascular treatment (EVT) of patients with posterior circulation large vessel occlusion (PC-LVO) strokes is not clear. Little data has been published and no randomized clinical trials have been conducted so far. We aimed to perform an updated meta-analysis to compare clinical and procedural outcomes between conscious sedation (CS) and general anesthesia (GA). Methods: We reviewed the literature of the studies reporting CS and GA in patients with endovascularly-treated PC-LVO. The primary outcome was the functional outcome at 3 months measured using the modified Rankin Scale (mRS). A good functional outcome was defined as having a mRS 0–2. Secondary outcomes were mortality at 3 months, final successful recanalization (modified Thrombolysis in Cerebral Infarction (mTICI) scale from 2b to 3) and complete recanalization (mTICI of 3) and times from stroke onset to EVT completion. Random-effects models were completed to pool the outcomes and the I2 value was calculated to assess heterogeneity. Findings: Eight studies with a total of 1351 patients were included. The pooled results reveal that CS use was associated with higher rates of good outcome (OR 2.41, 95% CI 1.58–3.64, I2 = 49.67%) and with lower mortality at 3 months (OR 0.48, 95% CI 0.28–0.82, I2 =57.11%). No significant differences were observed in the final reperfusion rates, procedural duration, and time from stroke onset to EVT completion. Conclusion: In this meta-analysis, GA was associated with significantly lower rates of functional independence at 3 months in patients with PC-LVO strokes.
Collapse
Affiliation(s)
- Mikel Terceño
- Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
- Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
- Mikel Terceño, Unitat d’Ictus, Servei de Neurologia, Hospital Universitari Doctor Josep Trueta de Girona, Av de França s/n, Girona 17007, Spain.
| | - Saima Bashir
- Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
- Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
| | - Juan Cienfuegos
- Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
- Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
| | - Alan Murillo
- Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
- Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
| | - Víctor Augusto Vera-Monge
- Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
- Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
| | - Laura Pardo
- Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
- Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
| | - Montserrat Reina
- Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
- Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
| | - Carme Gubern-Mérida
- Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
- Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
| | - Dolors Puigoriol-Illamola
- Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
- Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
| | - Laia Carballo
- Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
- Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
| | - Anna Costa
- Department of Anesthesiology and Critical Care Medicine, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
| | - Maria Buxó
- Statistical and Methodological Department, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
| | - Joaquín Serena
- Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
- Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
| | - Yolanda Silva
- Stroke Unit, Department of Neurology, Hospital Universitari Doctor Josep Trueta de Girona, Girona, Spain
- Cerebrovascular Pathology Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain
| |
Collapse
|
4
|
Abstract
One-fifth of strokes occur in the territory of the posterior circulation, but
their management, particularly acute reperfusion therapy and neurointervention
procedures for secondary prevention, has received much less attention than
similar interventions for the anterior circulation. In this review, we overview
the treatment of posterior circulation stroke, including both interventions in
the acute setting and secondary prevention. We focus on areas in which the
management of posterior circulation stroke differs from that of stroke in
general and highlight recent advances. Effectiveness of acute revascularization of posterior circulation strokes remains
in large parts unproven. Thrombolysis seems to have similar benefits and lower
hemorrhage risks than in the anterior circulation. The recent ATTENTION and
BAOCHE trials have demonstrated that thrombectomy benefits strokes with basilar
artery occlusion, but its effect on other posterior occlusion sites remains
uncertain. Ischemic and hemorrhagic space-occupying cerebellar strokes can
benefit from decompressive craniectomy. Secondary prevention of posterior circulation strokes includes aggressive
treatment of cerebrovascular risk factors with both drugs and lifestyle
interventions and short-term dual anti-platelet therapy. Randomized controlled
trial (RCT) data suggest basilar artery stenosis is better treated with medical
therapy than stenting, which has a high peri-procedural risk. Limited data from
RCTs in stenting for vertebral stenosis suggest that intracranial stenosis is
currently best treated with medical therapy alone; the situation for
extracranial stenosis is less clear where stenting for symptomatic stenosis is
an option, particularly for recurrent symptoms; larger RCTs are required in this
area.
Collapse
Affiliation(s)
- Hugh S Markus
- Department of Clinical Neurosciences, University of Cambridge, Cambridge UK 2152
| | - Patrik Michel
- Stroke Center, Neurology Service, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Switzerland
| |
Collapse
|